HCW Biologics (HCWB) Current Assets (2020 - 2025)
HCW Biologics' (HCWB) quarterly Current Assets came in at $2.3 million in Q4 2025, down 59.91% YoY from $5.7 million in Q4 2024, and up 43.8% on a QoQ basis from $1.6 million in Q3 2025.
HCW Biologics (HCWB) Current Assets (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Current Assets data on file, last reported at $2.3 million in Q4 2025.
- Quarterly Current Assets fell 59.91% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (down 59.91% YoY) and the FY2025 annual result came in at $2.3 million, down 59.91% from the prior year.
- Current Assets grew to $2.3 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $43.6 million in Q3 2021 to a low of $1.6 million in Q3 2025.
- A 5-year average of $17.1 million and a median of $10.0 million in 2021 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets soared 244.69% — and 2024, when it plunged 87.95%.
- Tracing HCWB's Current Assets over 5 years: stood at $40.5 million in 2021, then fell by 15.83% to $34.1 million in 2022, then tumbled by 81.2% to $6.4 million in 2023, then retreated by 11.02% to $5.7 million in 2024, then slumped by 59.91% to $2.3 million in 2025.
- The last three Current Assets figures came in at $2.3 million (Q4 2025), $1.6 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 2.90 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 2.09 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 6.21 Mn |
| Dec 31, 2023 | 6.40 Mn |
| Sep 30, 2023 | 13.85 Mn |
| Jun 30, 2023 | 19.80 Mn |
| Mar 31, 2023 | 29.94 Mn |
| Dec 31, 2022 | 34.07 Mn |
| Sep 30, 2022 | 28.71 Mn |
| Jun 30, 2022 | 34.63 Mn |
| Mar 31, 2022 | 37.91 Mn |
| Dec 31, 2021 | 40.48 Mn |
| Sep 30, 2021 | 43.56 Mn |
| Jun 30, 2021 | 10.05 Mn |
| Dec 31, 2020 | 12.15 Mn |